Total Clarity Wealth Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20
Closed -$9K 919
2021
Q4
$9K Buy
+20
New +$8.61K ﹤0.01% 725

Other funds holding WST

Total Clarity Wealth Management's WST Position: Q1 2022 in Review

Total Clarity Wealth Management sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 20 shares — an estimated $9K sold.

Total Clarity Wealth Management first reported a position in WST in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 717 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • Total Clarity Wealth Management reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 20 West Pharmaceutical shares in Q1 2022, an estimated $9K.
  • Total Clarity Wealth Management first reported a position in West Pharmaceutical in Q4 2021 and held it in 1 quarter.
  • Total Clarity Wealth Management's West Pharmaceutical position peaked at $9K in Q4 2021.
  • 717 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on Total Clarity Wealth Management's 13F filing for Q1 2022, filed 29 Apr 2022.